LONDON: Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced its intention to list entire issued and to be issued ordinary share capital of the Company to the AIM market of the London Stock Exchange. Belluscura’s first product, the X-PLO2 RTM, is a lightweight FDA cleared portable oxygen…